Long-term lecanemab data show increased patient benefit with maintained safety profile

Go back to Long-term lecanemab data show increased patient benefit with maintained safety profile
BARNES GROUP, Inc. (NYSE: B) Delayed: 40.83 -0.23 (0.56%)
Previous Close $41.06    52 Week High $44.27 
Open $40.68    52 Week Low $30.07 
Day High $40.98    P/E 31.17 
Day Low $40.59    EPS $1.31 
Volume 2,875,863       

BIOAMBER, Inc. (NASDAQ: BIOA) Delayed: 5.94 -0.4 (6.31%)
Previous Close $6.34    52 Week High $8.73 
Open $6.24    52 Week Low $2.86 
Day High $6.30    P/E N/A 
Day Low $5.88    EPS $-3.82 
Volume 482,162